GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO Jay Saccaro - VP and CFO Conference Call Participants Anthony Petrone - Mizuho Financial Group Craig Bijou - BofA Securities Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Robbie Marcus - JPMorgan Operator Good day, and thank you for standing by. Welcome to the GE HealthCare Fourth Quarter and Full Year 2024 Earnings Conference Call.
GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises
GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
GE HealthCare Tops Q4 EPS Forecasts
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (GEHC -1.30%) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27.
GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago.
GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.
GE HealthCare Posts Q4 Profit Above Expectations
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates.
GE Healthcare's business grows with boost from imaging and diagnostic drug units
The company said it was “pleased with
GE HealthCare Stock Rises on Strong Earnings and Outlook
The medical imaging company issues solid guidance for 2025.
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
GEHC Stock May Rise With $138M Investment in Cork Facility Expansion
GE HealthCare invests $138M to expand its Cork facility to enhance manufacturing capacity for life-saving imaging contrast media and strengthen its global supply chain.
GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series
GE HealthCare launches the enhanced Voluson Expert Series to advance women's health with faster, more precise imaging for improved care in obstetrics and gynecology.
